ne.achebe
Submits third-party assay reports on material purchased directly. Based in Linköping.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.11%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041645 | SS-31 (Elamipretide) | FGP | FGP-2601-R8955 | Janoshik | 2026-Q2 | 97.83 | 4.05 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-043325 | Ipamorelin | CPC | CPC-2508-Y1913 | PeptideMeter | 2026-Q1 | 98.11 | 5.61 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041799 | Liraglutide | ASY | ASY-{CAT}-2101 | Kestrel | 2025-Q4 | 99.93 | 3.97 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021075 | L-Glutathione (reduced) | BCH | BCH-2508-X4357 | Medutest | 2025-Q3 | 97.44 | 6.63 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020892 | Enclomiphene citrate | WXT | WXT-2506-V2798 | VendorInvestigate | 2025-Q3 | 98.91 | 4.29 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-019187 | PEG-MGF | SinoPep | SNP-2411-S4752 | Janoshik | 2025-Q1 | 97.17 | 4.55 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018847 | Dihexa | FGP | FGP-2408-S8496 | Nordanalyt | 2025-Q1 | 99.65 | 6.46 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004586 | Semaglutide | JEEP | JEEP-2403-V9444 | Nordanalyt | 2024-Q3 | 99.50 | 2.26 | 107.2 | Buyer-sourced | 0 | PASS |
| AX-2024-005077 | SS-31 (Elamipretide) | SSA | SSA-2408-G7111 | Janoshik | 2024-Q3 | 97.97 | 6.06 | 101.6 | Buyer-sourced | 0 | FAIL |